
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions Corp has demonstrated resilience through its diversified revenue streams, as evidenced by robust performance in international markets, particularly in bio-protection products and adjuvant sales in the US and Brazil. The company’s crop protection portfolio remains strong, with potential for a rebound in Argentine demand despite previous market share losses domestically. Moreover, the anticipated growth in international markets for HB4 wheat revenue highlights the company's strategic positioning to benefit from future expansion opportunities, supporting a positive long-term outlook.
Bears say
Bioceres Crop Solutions has experienced a significant decline in revenue driven by weaker demand in its Crop Protection and Crop Nutrition segments, particularly in Argentina, where revenues for Crop Nutrition dropped approximately 34% year-over-year to around $25 million. The company's transition to a licensing-based business model, moving away from seed production and breeding, has notably contributed to a staggering 75% year-over-year decrease in revenues for Seed & Integrated products, resulting in revenues of approximately $8 million. Additionally, the ongoing challenges of lower corn acreage and pricing pressures in Argentina’s fertilizer market have further exacerbated the company's financial difficulties, contributing to a negative outlook.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares